Cronos Group (TSE:CRON) Hits New 1-Year High – Should You Buy?

Shares of Cronos Group Inc. (TSE:CRON) reached a new 52-week high during trading on Monday . The stock traded as high as C$4.72 and last traded at C$4.71, with a volume of 79273 shares trading hands. The stock had previously closed at C$4.58.

Analyst Upgrades and Downgrades

Separately, TD lifted their price objective on shares of Cronos Group from C$5.50 to C$6.00 and gave the stock a “buy” rating in a research note on Monday, August 10th. Three analysts have rated the stock with a Buy rating, According to MarketBeat.com, the company has an average rating of “Buy” and an average target price of C$4.92.

Cronos Group Trading Up 2.3%

The company has a debt-to-equity ratio of 0.12, a quick ratio of 24.01 and a current ratio of 16.18. The company has a market capitalization of C$1.79 billion, a price-to-earnings ratio of 25.53, a price-to-earnings-growth ratio of 0.12 and a beta of 1.13. The firm has a fifty day moving average price of C$4.07 and a 200-day moving average price of C$3.79.

About Cronos Group

Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S.